Lifecome Biochemistry Co.,Ltd. (SHE:002868)
China · Delayed Price · Currency is CNY 37.75
-0.32 (-0.84%)
Mar 30, 2026, 3:04 PM CST
Lifecome Biochemistry Market Cap
Lifecome Biochemistry has a market cap or net worth of 5.92 billion as of March 27, 2026. Its market cap has increased by 122.37% in one year.
Market Cap
5.92B
Enterprise Value
6.37B
Revenue
516.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.75
Market Cap Chart
Since May 3, 2017, Lifecome Biochemistry's market cap has increased from 2.63B to 5.92B, an increase of 125.24%. That is a compound annual growth rate of 9.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 5.87B | 11.98% |
| Dec 31, 2025 | 5.24B | 68.80% |
| Dec 31, 2024 | 3.10B | -4.84% |
| Dec 29, 2023 | 3.26B | -59.95% |
| Dec 30, 2022 | 8.14B | 381.32% |
| Dec 31, 2021 | 1.69B | -17.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 6.82B |
| Jiangsu Aidea Pharmaceutical Group | 6.74B |
| Shenzhen Weiguang Biological Products | 6.24B |
| Xiangxue Pharmaceutical | 6.23B |
| GemPharmatech | 6.00B |
| R&G PharmaStudies | 5.91B |
| Beijing Konruns Pharmaceutical | 5.85B |
| Shanghai OPM Biosciences | 5.80B |